Biggest News Aggregation in the World
๐Ÿ“ฐ Molecule Type News

Page 5 - Molecule Type News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Molecule Type. Real-time updates on events, politics, business and more.

Pharmaceutical Excipients Global Market Report 2022-2029: Source, Products, Functionality, and Dosag

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Excipients Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.The pharmaceutical excipients global market is expected to grow at mid single-digit CAGR from 2022 to 2029 to reach $15,439.6 million by 2029. The pharmaceutical excipi...
United States United Kingdom Disintegrant Excipients Gmbh Dfe Pharma Povidone Excipients Oleochemical Excipients

Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market to Register 4.9% CAGR from 2023 to 2033 |

During the forecast period 2023 to 2033, the atypical hemolytic uremic syndrome (ahus) treatment market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valu...
New York United States United Arab Emirates Abbott Medtronic Alexion Pharmaceuticals Route Of Administration Oral

South Korean Injectable Drugs Market is expected to exhibit a 4.3% CAGR from 2022 to 2032

[342 Pages Report] The global dialysis equipment market size is projected to be valued at US$ 17,871.8 Mn in 2022 and is estimated to surpass a valuation of US$ 23,629.2 Mn by 2032. The sales of dialysis equipment are likely to rise at a CAGR of 4.8% from 2022 to 2032.Cancer, cardiovascular diseases, and metabolic d...
New York United States United Arab Emirates Samsung Biologics Glaxosmithkline Plc Sun Pharmaceutical Industries Ltd

Atypical Hemolytic Uremic Syndrome Treatment Market to Register 4.9% CAGR from 2023 to 2033

During the forecast period 2023 to 2033, the atypical hemolytic uremic syndrome (ahus) treatment market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valu...
New York United States Abbott Medtronic Alexion Pharmaceuticals Route Of Administration Oral Teva Pharmaceuticals Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science